<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="correction">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2016.00337</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Correction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Corrigendum: Characterization of T-bet and Eomes in Peripheral Human Immune Cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Knox</surname> <given-names>James J.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/148158"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Cosma</surname> <given-names>Gabriela L.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/144063"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Betts</surname> <given-names>Michael R.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x0002A;</xref>
<uri xlink:href="http://frontiersin.org/people/u/37988"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>McLane</surname> <given-names>Laura M.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x0002A;</xref>
<uri xlink:href="http://frontiersin.org/people/u/158278"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Microbiology, Perelman Institute for Immunology, University of Pennsylvania</institution>, <addr-line>Philadelphia, PA</addr-line>, <country>USA</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Immunology, Thomas Jefferson University</institution>, <addr-line>Philadelphia, PA</addr-line>, <country>USA</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Bruno Laugel, Cardiff University, UK</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: David K. Cole, Cardiff University, UK</p></fn>
<corresp content-type="corresp" id="cor1">&#x0002A;Correspondence: Michael R. Betts, <email>betts&#x00040;mail.med.upenn.edu</email>; Laura M. McLane, <email>lmclane&#x00040;mail.med.upenn.edu</email></corresp>
<fn fn-type="other" id="fn001"><p>Specialty section: This article was submitted to T Cell Biology, a section of the journal Frontiers in Immunology</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>08</day>
<month>09</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>7</volume>
<elocation-id>337</elocation-id>
<history>
<date date-type="received">
<day>10</day>
<month>08</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>08</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2016 Knox, Cosma, Betts and McLane.</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>Knox, Cosma, Betts and McLane</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" journal-id="Front Immunol" journal-id-type="nlm-ta" vol="5" page="217" xlink:href="24860576" ext-link-type="pubmed">A corrigendum on <article-title>Characterization of T-bet and Eomes in Peripheral Human Immune Cells</article-title> by Knox JJ, Cosma GL, Betts MR, McLane LM. Front Immunol (2014) 5:217. doi: <object-id>10.3389/fimmu.2014.00217</object-id></related-article>
<kwd-group>
<kwd>T-box transcription factors</kwd>
<kwd>T-cells</kwd>
<kwd>NK cells</kwd>
<kwd>B-cells</kwd>
<kwd>T-bet</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="2"/>
<word-count count="790"/>
</counts>
</article-meta>
</front>
<body>
<p>The corrigendum regards data and text for the final figure of the manuscript, Figure <xref ref-type="fig" rid="F7">7</xref>:</p>
<p>Subsequent analysis of T-bet levels in human lymphocytes comparing different permeabilization procedures (eBioscience FoxP3 transcription factor kit, BD Pharmingen Cytofix/Cytoperm) has revealed variable findings in the level of T-bet expression detected within certain lymphocyte populations. While this does not change our conclusions for the majority of the populations assessed in this study, B cells in particular show differences under these conditions. Specifically, permeabilization <italic>via</italic> the eBioscience FoxP3 transcription factor staining buffer set indicates that subpopulations of memory B cells express significantly higher levels of T-bet (MFI) compared to plasmablasts, and that plasmablasts express T-bet only at low levels. Subsequent RNA transcript analysis confirms that plasmablasts express T-bet RNA at a level comparable to na&#x000EF;ve B cells. Together, in combination with fluorescence-minus-one and isotype control studies, these new findings suggest that subsets memory B cells, not plasmablasts, express the highest levels of T-bet in the B cell compartment and plasmablasts express T-bet at a lower frequency than is reported in Figure <xref ref-type="fig" rid="F7">7</xref>.</p>
<p>Figure <xref ref-type="fig" rid="F7">7</xref> Legend should read:</p>
<p><bold>(C)</bold> Histograms depicting T-bet expression levels in B-cells and NK cells from a representative donor. Histograms represent the following subsets: na&#x000EF;ve B-cells (thick black line), memory B-cells (shaded gray), plasmablasts (thin black line), CD56<sup>bright</sup> NK cells (gray line), and CD56<sup>dim</sup> NK cells (shaded black).</p>
<p>B-cell results section should be titled &#x0201C;T-bet is predominantly expressed in mature memory B-cells&#x0201D; and should read:</p>
<p>While Eomes was undetectable in B-cells (data not shown), we found T-bet in &#x0007E;10% of B-cells (Figure <xref ref-type="fig" rid="F7">7</xref>B). This T-bet expression was largely relegated to memory B-cells, with significantly lower amounts observed in transitional/immature B-cells, na&#x000EF;ve B-cells, and plasmablasts (Figure <xref ref-type="fig" rid="F7">7</xref>B). Greater than 15% of memory B-cells expressed T-bet, a significantly higher frequency than that of all other B-cell populations, suggesting that T-bet may play a particularly important role in memory B-cell function.</p>
<p>The discussion related to T-bet expression in plasmablasts should be reconsidered as follows:</p>
<fig id="F7" position="float">
<label>Figure 7</label>
<caption><p><bold>T-bet expression in antigen-experienced B-cells</bold>. <bold>(A)</bold> T-bet gating strategy for B-cell populations is shown. Transitional, na&#x000EF;ve, memory B-cells, and plasmablasts populations are depicted as a contour plot overlaying a density plot of total B-cells. T-bet<sup>&#x0002B;</sup> events are gated from a representative donor. <bold>(B)</bold> The frequency of T-bet<sup>&#x0002B;</sup> B-cells within B-cell subpopulations is shown. Each symbol represents an individual subject. Statistical differences of interest, as measured using non-parametric Wilcoxon matched, paired two-tailed <italic>t</italic> tests, are described in the text. &#x0002A;<italic>p</italic>&#x02009;&#x0003C;&#x02009;0.04. <bold>(C)</bold> Histograms depicting T-bet expression levels in B-cells and NK cells from a representative donor. Histograms represent the following subsets: na&#x000EF;ve B-cells (thick black line), memory B-cells (shaded gray), plasmablasts (thin black line), CD56<sup>bright</sup> NK cells (gray line), and CD56<sup>dim</sup> NK cells (shaded black).</p></caption>
<graphic xlink:href="fimmu-07-00337-g007.tif"/>
</fig>
<p>We found that T-bet is not significantly expressed in transitional/immature B-cells, na&#x000EF;ve B-cells, and plasmablasts, but is highly expressed in subsets of memory-B cells. Reduced frequencies of T-bet expression in plasmablasts indicate a specific role for T-bet at the memory B-cell stage of development, which may no longer be necessary after further differentiation to the plasmablast stage.</p>
<sec id="S1">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
</article>